title: [Anti-virus effect of combination of attenuated measles virus with 3TC on duck hepatitis B model].
abstract: OBJECTIVE
  To evaluate the anti-virus effect of combination of attenuated measles virus with 3TC on duck hepatitis B model.
  
  
  METHODS
  Guanzhou brown spot ducklings infected with DHBV were divided into three groups. Drug treatments including measles vaccine, 3TC and both measles vaccine and 3TC were given in the 13th day after the infection, respectively. Serum samples were obtained from all ducklings before, during and after treatment at different times and stored at -70 degrees C. DHBV DNA was detected by Dot-blot hybridization.
  
  
  RESULTS
  Compared with the levels of DHBV DNA before and after treatment, no statistic difference was found in group of 3TC alone. The levels of DHBV DNA were not changed in group of measles vaccine alone in early stage, but decrease of DHBV DNA occurred after stopping treatment (comparison of the levels T13 with before treatment and T13 of positive group, P < 0.01 and P < 0.05, respectively). DHBV DNA level in group of measles vaccine combined with 3TC was obviously lower at 5th day after the treatment than in both measles vaccine and 3TC alone groups at the same time(P < 0.05 and P < 0.01, respectively), and it remained low when the treatment was discontinued.
  
  
  CONCLUSIONS
  Attenuated measles virus combined with 3TC may have early and long-lasting inhibiting effect on the replication of DHBV.
authors.affiliation: 8th People's Hospital of Guangzhou, Guangzhou 510060, China.
authors.forename: Z
authors.initials: Z
authors.lastname: Yang
authors.forename: X
authors.initials: X
authors.lastname: Deng
authors.forename: F
authors.initials: F
authors.lastname: Zhang
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D018347:Hepadnaviridae Infections / Q000628:therapy*; D015611:Hepatitis B Virus, Duck; D006524:Hepatitis, Viral, Animal / Q000628:therapy*; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008458:Measles Vaccine / Q000627:therapeutic use*; D011897:Random Allocation; D014613:Vaccines, Attenuated / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D008458:Measles Vaccine; D014613:Vaccines, Attenuated; D019259:Lamivudine